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Gonococci isolated from localized urogenital infections usually possess one or more protein II (P.11) species
in the outer membrane, but the structural and antigenic variation of these proteins among different gonococcal
strains has made it difficult to determine if specffic proteins of the P.11 class are associated with particular sites
or types of infection. A recent outbreak of gonorrhea in Durham, N.C., was unusual in that over 200 isolates
were derived from a single strain, which provided an opportunity to address these questions. The P.II profile
of 54 isolates was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of outer membrane
proteins. At least seven distinct P.II proteins were seen; no single protein or combination of proteins
predominated in the different isolates, and there was no association of P.11 profile with site of isolation.
Gonococci recovered from the same patient at different times had different P.II profiles, confirming that P.11
variation occurred in vivo.
The protein II (P.11) species of Neisseria gonorrhoeae are
a family of heat-modifiable, outer membrane proteins that
undergo a complex type of phase and antigenic variation.
Some strains have been shown to produce at least six
electrophoretically distinct P.II proteins (1, 13). A single
organism is capable of expressing from zero to at least three
P.II species in different combinations (8, 13, 16), and spon-
taneous changes in the state of P.II expression occur at a
high frequency (11). Gonococci possessing certain P.11 pro-
teins often show increased colonial photo-opacity (8, 14),
slightly increased resistance to some antibiotics (9), better
attachment to buccal epithelial cells (9), altered serum resist-
ance (6, 9), and decreased sensitivity to steroid hormones
(12).
Gonococci expressing P.II are associated with infections
localized to the urogenital mucosa. Organisms isolated from
uncomplicated infection in men or at particular times in the
menstrual cycle in women often express one or more P.II
proteins (5, 17). Gonococci isolated from a disseminated
gonococcal infection generally lack P.11 (3, 5). However,
because of the variation in electrophoretic mobility and
antigenicity of P.11 proteins of different strains (15), it has
been difficult to draw conclusions about the extent of P.II
variation in vivo or about the possible association of a
specific P.II with the site of isolation or type of infection.
Zak et al. (17) recently characterized P.11 profiles of strains
from seven groups of sexual partners; gonococci from the
same group (up to three partners) were derived from the
same strain but had differences in P.II expression. That
study confirmed that P.II variation does occur in vivo, but
because of the limited number of isolates available from each
strain, it was impossible to draw conclusions about the
number of different P.11 proteins that were expressed by
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each strain or about the infection site specificity of P.11
expression.
An outbreak of penicillin-resistant gonorrhea that oc-
curred in 1983 in Durham, N.C. (4), gave us an opportunity
to address some of these questions about in vivo expression
of P.11. Nearly 200 of the isolates collected during this
outbreak were derived from a single strain. We exmained the
P.11 profiles of some of these isolates by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis to assess the ex-
tent of P.11 variation in this collection.
All samples surveyed met the following criteria for belong-
ing to the same strain: identical antibiotic MICs, the same
protein I monoclonal antibody serovar (WII/WIII, serovari-
ant IB-1) and apparent molecular weight by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis, and identical nu-
tritional requirements (proline auxotrophs). The clinical and
epidemiological features of the outbreak and the methods
used in strain typing will be described separately (H. Faruki,
R. N. Kohmescher, W. P. McKinney, and P. F. Sparling,
submitted for publication). To minimize shifts in P.11 profile
occurring during passage in the laboratory, samples were
passaged only once after initial isolation and frozen at
-70°C. Gonococci were grown on Difco GCB agar with the
supplements of Kellogg et al. (7) for 18 to 20 h at 37°C in 4%
CO2. Colony phenotypes were determined by examining
colonies with a dissecting microscope, using the criteria of
Swanson (13).
An additional qualification for inclusion in this survey was
that at least 90% of the colonies from a sample be of the same
photo-opacity when examined with a dissecting microscope.
Since colonial opacity is often associated with P.II expres-
sion, a sample containing a mixture of opacity variants could
contain organisms expressing different P.II species. Hetero-
geneous P.11 populations would be difficult to interpret, as it
could be possible that some of the organisms changed P.11
expression after initial isolation. Approximately 20% of the
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FIG. 1. P.11 profiles of eight penicillin-resistant isolates (lanes A through H) recovered from male patients. Materials in lanes A through
H were solubilized at 37C for 60 min, and lanes A' through H' show the same preparations solubilized at 100PCfor 5 mm. The P.11 proteins
in lanes F and G showed the same migration after 370C solubilization but migrated with different apparent molecular weights after 100'C
solubilization. Therefore, they are distinct P.11 species. Molecular weight standards (lane 5): phospholipase B, 94,000; bovine serum albumin,
68,000; ovalbumin, 43,000; carbonic anhydrase, 30,000; soybean trypsin inhibitor, 20,100; and lysozyme, 14,300. P.1, Protein
TABLE 1. P.II expression in isolates from randomly chosen male




Source No. of No. of different No of PIisolates different combinations eproeisse e
examined P.11 proteins of P.11 expressed per
proteins isolate
Male urethra 13 6 12 1-3
Female cervix 13 7 13 0-3
clinical isolates displayed a mixed colonial opacity and were
not studied further.
Outer membranes were isolated by rapid passage of
gonococci through a 22-gauge needle in 200 mM lithium
acetate buffer, pH 6.0 (8). Cellular debris was centrifuged
and discarded. Outer membrane blebs were pelleted by
centrifugation at 100,000 x g for 2 h at 4°C. Pellets were
suspended in water and stored at -70°C. Samples containing
approximately 25 ,ug of protein were solubilized at 37°C for
60 min or at 100°C for 5 min and were subjected to sodium
dodecyl sulfate-polyacrylamide gel electrophoresis on 4 to
30% gradient gels with Laemmli buffers (10) as previously
described (1). Gels were stained with Coomassie brilliant
blue.
We characterized urethral isolates from randomly chosen
male patients, cervical isolates from randomly chosen fe-
TABLE 2. Pairs of strains isolated from two infected sites of one
patient or from the same site at two different times
No. of
No. of No. of pairs pairs No. of pairs
Source pairs with identical with one with different
examined P.11 proteins P.11 the P.II proteins
same
Same patient, 7 3 2 2
different sitesa
Same patient, 7 0 1 6
different timeb
aCervical and urethral isolates obtained at the same time.
b Time interval between samples ranged from 5 days to 2 months.
male patients isolates from different anatomical sites of the
same patient (cervical and urethral isolates from females),
and isolates from the same patient over a period of time
(treatment failures or repeat infections). At least seven
electrophoretically distinct P.II species were seen in this
collection of 54 isolates. With the exception of one isolate
from a female patient that produced no P.II protein, all of the
gonococcal isolates examined produced from one to three
P.II species. Figure 1 shows representative profiles of iso-
lates from male patients. Results of other comparisons are
summarized in Tables 1 and 2. Isolates from a single patient
at different times were heterogeneous in P.II composition. A
more homogeneous pattern was observed with isolates from
two infected sites of a single patient. Of the seven pairs
examined, three had identical P.11 patterns; in two other
pairs, one of the two P.IIs was identical in apparent molecu-
lar weight. There was no detectable association of particular
P.II species with the sex of the host or the site of isolation.
These results confirm and extend those of Zak et al. (17),
who demonstrated that P.II variation of gonococci does
occur in vivo. By analyzing a larger number of isolates
derived from a single gonococcal strain, we were able to test
the hypothesis that differences in P.11 profile of a strain may
be associated with differences in its ability to establish or
maintain infection in particular microenvironments within
the host. If different P.II proteins conferred different tissue
tropisms upon gonococci, then organisms isolated from a
particular anatomical site might be expected to be similar in
P.11 expression. We detected no association of particular
P.II species with infection in different sites but did confirm
that almost all of the isolates from uncomplicated gonococ-
cal infection by this strain produced one or more P.II
proteins.
Factors that regulate P.11 expression or that influence the
selection of different P.11-bearing variants in the host are
unknown. Antibody specific for P.II is present in sera from
patients with uncomplicated disease (17), and anti-P.II anti-
body can be bactericidal for gonococci expressing that
protein (1). Therefore, it has been suggested that the immune
response to P.II might influence the survival of particular
P.II-bearing gonococci. Other host factors that might affect
the selection of different P.11 variants include proteases (2)
and steroid hormones (12). Further studies are required to
understand mechanisms for the generation of P.II diversity
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and the selective pressures that operate in the infected host
to maintain that diversity.
We thank H. Faruki for sharing unpublished data with us and for
helpful discussions. The expert assistance of Lynn Brooks in
preparing this manuscript is gratefully acknowledged.
This investigation was supported by Public Health Service grant
A115036 from the National Institute of Allergy and Infectious
Diseases.
LITERATURE CITED
1. Black, W. J., R. S. Schwalbe, I. Nachamkin, and J. G. Cannon.
1984. Characterization of Neisseria gonorrhoeae protein II
phase variation by use of monoclonal antibodies. Infect. Im-
mun. 45:453-457.
2. Blake, M. S., E. C. Gotschlich, and J. Swanson. 1981. Effects of
proteolytic enzymes on the outer membrane proteins of Neis-
seria gonorrhoeae. Infect. Immun. 33:212-222.
3. Draper, D. L., J. F. James, G. F. Brooks, and R. L. Sweet.
1980. Comparison of virulence markers of peritoneal and fallo-
pian tube isolates with endocervical Neisseria gonorrhoeae
isolates from women with acute salpingitis. Infect. Immun.
27:882-888.
4. Fletcher, J. D., C. S. Chandler, P. F. Sparling, and M. P. Hines.
1983. Penicillin-resistant gonorrhea-North Carolina. Morbid.
Mortal. Weekly Rep. 32:273-275.
5. James, J. F., and J. Swanson. 1978. Color/opacity colonial
variants of Neisseria gonorrhoeae and their relationship to the
menstrual cycle, p. 338-343. In G. F. Brooks, E. C. Gotschlich,
K. K. Holmes, W. D. Sawyer, and F. E. Young (ed.), Im-
munobiology of Neisseria gonorrhoeae. American Society for
Microbiology, Washington, D.C.
6. James, J. F., E. Zurlinden, C. J. Lammel, and G. F. Brooks.
1982. Relationship of protein I and colonial opacity to serum
killing of Neisseria gonorrhoeae. J. Infect. Dis. 145:37-44.
7. Kellogg, D. S., Jr., W. L. Peacock, Jr., W. E. Deacon, L.
Brown, and C. I. Pirkle. 1963. Neisseria gonorrhoeae. I. Viru-
lence genetically linked to clonal variation. J. Bacteriol. 85:
1274-1279.
8. Lambden, P. R., and J. E. Heckels. 1979. Outer membrane
protein composition and colonial morphology of Neisseria gon-
orrhoeae strain P9. FEMS Microbiol. Lett. 5:263-265.
9. Lambden, P. R., J. E. Heckels, L. T. James, and P. J. Watt.
1979. Variations in surface protein compositon associated with
virulence properties in opacity types of Neisseria gonorrhoeae.
J. Gen. Microbiol. 114:305-312.
10. Laemmli, U. K. 1970. Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature (London)
227:680-685.
11. Mayer, L. W. 1982. Rates of in vitro changes of gonococcal
colony opacity phenotypes. Infect. Immun. 37:481-485.
12. Salit, I. E. 1982. The differential susceptibility of gonococcal
opacity variants to sex hormones. Can. J. Biochem. 60:301-306.
13. Swanson, J. 1978. Studies on gonococcus infection. XIV. Cell
wall protein differences among color/opacity colony variants of
Neisseria gonorrhoeae. Infect. Immun. 21:292-302.
14. Swanson, J. 1982. Colony opacity and protein II compositions of
gonococci. Infect. Immun. 37:359-368.
15. Swanson, J., and 0. Barrera. 1983. Immunological characteris-
tics of gonococcal outer membrane protein II assessed by
immunoprecipitation, immunoblotting, and coagglutination. J.
Exp. Med. 157:1405-1420.
16. Walstad, D. L., L. F. Guymon, and P. F. Sparling. 1977. Al-
tered outer membrane protein in different colonial types of
Neisseria gonorrhoeae. J. Bacteriol. 129:1623-1627.
17. Zak, K., J.-L. Diaz, D. Jackson, and J. E. Heckels. 1984.
Antigenic variation during infection with Neisseria gonor-
rhoeae: detection of antibodies to surface proteins in sera of
patients with gonorrhea. J. Infect. Dis. 149:166-173.
252 NOTES
